News
Most people know of Type 1 and Type 2 diabetes, but not all know how their causes differ. We asked Dr. Rodica Busui, the president of Medicine and Science at the American Diabetes Association.
ORLANDO, Fla. — The inhaled insulin Afrezza combined with a long-acting basal analog offers a non-inferior insulin treatment option for people with type 1 diabetes, new phase 4 data suggest.
Type 1 diabetes, which affects far fewer people, is a chronic disease where the body’s own immune system typically attacks insulin-producing cells in the pancreas, creating a lifelong need to ...
“Both adult and childhood-onset type 1 diabetes are due to autoimmune destruction of cells in the pancreas, known as beta cells, that produce insulin,” says Rita R. Kalyani, MD, MHS, an ...
BUFFALO, N.Y.— Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.
What is Type 1 diabetes? Only 5-10% of all diabetics have Type 1, which occurs when the cells meant to produce insulin in the body do not function properly, said Dr. Kevin Peterson, Vice President ...
Type 1 diabetes demands precise carbohydrate counting and insulin timing, while type 2 focuses more on overall dietary patterns and weight management. Exercise recommendations vary between types ...
Type 1 diabetes is a reaction that stops your body from making insulin altogether, with no prevention or cure. One of Dr. Dandona’s patients, Ginny Bullock shared her struggles with her Type 1 ...
Previously known as juvenile diabetes or insulin-dependent diabetes, Type 1 diabetes results when the pancreatic beta cells are destroyed by the immune system. Beta cells are the only cell type in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results